Studies on Left Ventricular Hypertrophy Regression in Arterial Hypertension: A Clear Message for the Clinician?
Open Access
- 1 April 2008
- journal article
- review article
- Published by Oxford University Press (OUP) in American Journal of Hypertension
- Vol. 21 (4) , 458-463
Abstract
Background. Evidence-based medicine should provide clear and unbiased information to clinicians. We conducted an analysis on published randomized trialKeywords
This publication has 51 references indexed in Scilit:
- 2007 Guidelines for the Management of Arterial HypertensionJournal Of Hypertension, 2007
- Effect of Irbesartan Versus Atenolol on Left Ventricular Mass and VoltageHypertension, 2004
- Left Ventricular Concentric Geometry During Treatment Adversely Affects Cardiovascular Prognosis in Hypertensive PatientsHypertension, 2004
- Comparative effects of chronic ACE inhibition and AT1 receptor blocked losartan on cardiac hypertrophy and renal function in hypertensive patientsJournal of Human Hypertension, 2002
- Effects of Amlodipine and Lisinopril on Left Ventricular Mass and Diastolic Function in Previously Untreated Patients with Mild to Moderate Diastolic HypertensionBlood Pressure, 1998
- ACE inhibitor ramipril is more effective than the ??-blocker atenolol in reducing left ventricular mass in hypertension. Results of the RACE (ramipril cardioprotective evaluation) studyJournal Of Hypertension, 1995
- Association of change in left ventricular mass with prognosis during long-term antihypertensive treatmentJournal Of Hypertension, 1995
- Effect of Amlodipine on Left Ventricular Mass in the Amlodipine Cardiovascular Community TrialJournal of Cardiovascular Pharmacology, 1995
- Ramipril-Induced Regression of Left Ventricular Hypertrophy in Treated Hypertensive IndividualsHypertension, 1995
- Prognostic Implications of Echocardiographically Determined Left Ventricular Mass in the Framingham Heart StudyNew England Journal of Medicine, 1990